Base de gel-crème Cica apaisant

1. INCI et CAS

INCI: Madecassoside · CAS: 34540-22-2

2. Rôle dans la formule

Madecassoside is a purified triterpene glycoside from Centella asiatica. The guide level is for cosmetic leave-on chassis, not a wound-healing drug claim.

3. Niveaux d'emploi typiques (repère de formulation)

• 0.1–0.3% is listed for gels and gel-creams.
• Serums may use the guide range 0.1–0.5% for the formula.

Dissolve into water or an approved solvent. Avoid a long high-heat hold after addition.

4. Sources réglementaires et conformité mondiale

• If CosIng lists Madecassoside, that listing remains ingredient information; check rules for the intended market and use.
• The framework in Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Madecassoside is used, to be assessed for the complete formula intended for sale.
• Confirm the actual Madecassoside grade from supplier documentation and check requirements where the product will be sold.

5. Sécurité et évaluation des risques

This entry provides guidance for cosmetic use only; no drug approval or OTC-monograph status follows from this guide while finished-product patch and stability testing remain necessary.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; select packaging with the formula's oxidation sensitivity in mind; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Madecassoside highlights Centella marker.

• This ingredient reference provides no basis for drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This Madecassoside listing cannot verify skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI et CAS

INCI: Centella Asiatica Extract · CAS: 84696-21-9

2. Rôle dans la formule

Centella asiatica extract is used as a soothing botanical in leave-on gels and creams. Madecassoside content of the extract is supplier-specific and is not invented here.

3. Niveaux d'emploi typiques (repère de formulation)

• The gels use-level reference is 1–3% in this reference.
• The level shown for creams is 1–4% in this reference.
• The formulation record indicates 1–5% of the extract as supplied for serums in this reference.

Add in cool-down when the carrier is heat-sensitive. Guide pH about 5–6.

4. Sources réglementaires et conformité mondiale

• Use CosIng's information on Centella Asiatica Extract as a reference, then verify the specific grade and intended use under market rules.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the complete cosmetic containing Centella Asiatica Extract to receive its own safety assessment for the specific product as it will be marketed.
• Confirm the received Centella Asiatica Extract grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

The listed use rate is intended as a cosmetic-development guide; no drug approval or OTC-monograph status follows from this guide with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; for oxidation-sensitive formulas, consider an airless or pump pack; assess the confirmed formula for stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic role of Centella Asiatica Extract is presented as Centella botanical.

• The listed information does not establish a drug effect, a clinical cure, or certification status not established for the SKU.
• The Centella Asiatica Extract entry should not be used to substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI et CAS

INCI: Asiaticoside · CAS: 16830-15-2

2. Rôle dans la formule

Asiaticoside is a Centella triterpene glycoside used as a second marker in cica-style cosmetic guides.

3. Niveaux d'emploi typiques (repère de formulation)

• Gels and creams: 0.1–0.3%

Same cool-down handling as other Centella glycosides.

4. Sources réglementaires et conformité mondiale

• Database information on Asiaticoside does not replace review of the supplied grade and finished product under market rules.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require an assessment addressing the safety of the finished product that contains Asiaticoside at the level of the finished cosmetic product.
• Confirm the received Asiaticoside grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

The percentage is shown for cosmetic development; the note establishes neither drug approval nor OTC-monograph status while finished-product patch and stability testing remain necessary.

6. Stabilité et conditionnement

Keep bulk supplies closed, cool, and protected from sunlight; consider an airless or pump format when oxidation sensitivity warrants it; check the final package and formula together for compatibility and stability.

7. Formulations d'allégations (à faire / à éviter)

• Supports the second Centella marker

• The formulation note cannot verify claims of drug activity, a clinical cure, or an undocumented product certification.
• This cosmetic entry naming Asiaticoside cannot verify whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.